Cancer drug developer Inhibrx raises $40 million

May 28, 2019 sandiegobiotech News Comments Off on Cancer drug developer Inhibrx raises $40 million
Cancer drug developer Inhibrx raises $40 million
/

Using an array of technologies, San Diego biotech Inhibrx is attacking a wide variety of cancers